Reps and Warranties: 6 Clauses That Decide Your DTC Payout

When you sign a purchase agreement to sell your DTC brand, the representations and warranties section is not boilerplate. Every clause in it is a promise you are making about the state of the business, and each one is a legal trigger. If a promise turns out to be false, the buyer can claw money back out of escrow after close, and in a few specific cases, kill the deal before it closes. Most founders skim this section because it reads like lawyer language. The buyers on the other side of the table read every line, because it is where they get their money back if diligence turns up something you missed.

This is the clause-by-clause map operators ask us for before they enter a sale process. About 1 in 5 R&W-insured deals draws a formal claim, so the risk is real, not theoretical. Below is where the claims actually land, which six clauses trip up DTC sellers most, and the one clause that ends transactions outright.

What reps and warranties actually are, and what happens when they are wrong

Representations and warranties (reps and warranties, or R&W) are the seller's sworn statements about the business at the moment of sale. The financials are accurate. Taxes are filed. Contracts are valid and assignable. You own your brand. There are no undisclosed liabilities. These reps are near-universal in modern deals: 97% of agreements in the ABA 2025 Private Target M&A Deal Points Study carried a "fair presentation of financials" rep, and a separate "no undisclosed liabilities" rep appeared in the large majority of them.

When a rep is false, the mechanism is indemnification: the buyer files a claim, and the money comes out of an escrow holdback or, increasingly, from an R&W insurance policy. The market consensus for 2023-2024 puts claim frequency in the 15-20% range. Hunton Andrews Kurth cites roughly 20%; Cooley's 2024 market update lands at 16-17%; Aon's 2026 Global Claims Study reports that claim frequency ticked up marginally in North America after a quieter 2020-2022 stretch.

The timing matters more than founders expect. The most common survival period is 24 months (26% of deals), then 12 months (23%) and 18 months (19%). And for the first time, more than half of all R&W claim notices now arrive more than 12 months after close. When I talk to founders getting ready to sell, most of them are mentally planning for a clean break at closing. The data says the exposure window runs a full two years, and the claims are landing later inside it than they used to.

Where the claims actually land

Here is the part most sale-prep advice skips: the claims are not evenly spread. Two categories dominate the money.

Financial statements and material contracts together account for roughly 71% of everything paid out, even though financial-statement breaches make up fewer than 20% of claim notifications. Financial statements is the largest single category of payments, with Aon's 2026 data putting financial-statement breaches at 38% of paid losses on post-2019 policies. Compliance with laws is the single most frequent notification category at over 20% of notices, but it settles for less per claim. IP sits in the residual: rare by count, but the highest average payout when it hits.

The lesson for a seller is to spend your cleanup time where the payments concentrate. When we work with founders on sale prep, the instinct is usually to over-lawyer the exotic clauses. The money says the opposite: get your revenue recognition, your chargeback accruals, and your material-contract file airtight first, because that is where the losses actually leak.

The six clauses DTC founders get tripped up on

Across the deals we see, the same six clause categories generate almost all the friction for consumer brands. Each one has a specific DTC failure mode.

Tax is the one that quietly grows. SRS Acquiom's 2025 claims data shows tax and capitalization reps account for over half of all breach claims, and undisclosed-liability claims have more than doubled since 2022, now sitting at 24% of all R&W indemnification claims. For DTC brands, the two usual culprits are sales tax nexus (you crossed an economic-nexus threshold in a state and never registered) and unfiled international VAT. The pattern we see again and again is a brand that grew faster than its compliance stack. One operator we worked with had 18 months of unfiled EU VAT returns from an advisor error, with roughly 40,000 euros of exposure in a single country before you counted the rest. They had not disclosed it because they did not know the full scope. A buyer's tax review finds it in weeks.

IP ownership: the clause that terminates deals, not just triggers escrow

Every other clause on this list leads to a post-close fight over money. The IP ownership clause is different in kind: when it fails, it can end the transaction before it closes.

Here is why. When a buyer's counsel finds that a formula, trademark, or piece of branded packaging has clouded chain of title, the problem is not that the business is worth less. It is that you cannot cleanly transfer what you are selling. For DTC brands, clouded title almost always traces to one of three things: a contractor built a logo, a site, or product art without a signed work-for-hire assignment, so the contractor still owns it; a trademark is registered under a prior entity from before a restructure and was never reassigned; or a formula's ownership is split between the founder and a contract manufacturer. Mayer Brown's 2025 guidance flags anti-assignment clauses in key IP licenses as explicit deal-breakers, not indemnification triggers. An academic analysis on SSRN attributes a meaningful share of the 46-60% of M&A transactions that miss their objectives in part to exactly this: defects in IP chain of title and underestimated transfer restrictions.

We saw this play out with a consumer-goods brand in talks with an IP-backed fund. The fund's very first question was not about revenue. It was about the nature of the IP and who actually held the commercial rights, because the brand's products were sold under multiple names through retail partners and some formulas were licensed to private-label distributors under a different entity. That fragmentation is the chain-of-title question a serious buyer asks first. If the answer is messy, you do not get a lower price. You get a stalled deal. The fix is unglamorous and slow: run a trademark clearance search, confirm every registration sits under the selling entity, and paper the assignment for every contractor-created asset before a buyer ever asks.

How R&W insurance changes the math

R&W insurance has quietly rewired how this risk is allocated. It now covers 63% of private-target deals, up from 55% in 2023. And in an insured deal, the buyer's policy, not the seller's escrow, absorbs most warranty breaches.

That shift shows up in the deal terms. No-survival deals, where the seller's reps do not survive closing at all, rose from 30% to 41%. Insured sellers hold back roughly half the escrow of uninsured ones. The chart below shows the gap.

This does not mean an insured seller is off the hook. The insurer investigates the same breaches the buyer would, and it can pursue you directly for fraud. What insurance changes is the shape of the risk, not whether your reps have to be true. When I talk to founders who assume an R&W policy means they can be loose with disclosure, the correction is simple: the policy protects the buyer's recovery, not your accuracy. Clean reps still get you a cleaner, faster exit with less cash trapped in escrow.

The diligence audit your buyer will run, and how to get clean first

Almost every claim on the list above surfaces in the same place: a quality-of-earnings (QoE) review. A buyer plugs an accounting firm into your books, usually for three to six months, and restates your numbers. That is the window where inventory misstatements and undisclosed liabilities come to light. One buyer we sat across from framed his entire concern as a single question: how are you going to understand their books? His plan was a multi-month accounting review straight into the seller's QuickBooks. That is not unusual. That is the standard.

Here is the seller-side checklist we run before a brand enters a process:

• Revenue recognition. Make sure revenue is booked when earned, net of returns and refunds, not on gross cash receipts. DTC returns and chargebacks are the most commonly restated line.
• Inventory write-downs. Aged and dead stock carried at full cost is a financial-statement rep waiting to break, and it is the same problem that quietly ties up cash before a sale is ever on the table (more on that in our guide to freeing trapped working capital). One brand we worked with had deferred a 276,000 dollar dead-stock write-off for months. A QoE team writes it down on day one, and the seller's inventory rep becomes false. Take the write-off before diligence.
• Sales tax nexus and VAT. Map every state where you crossed an economic-nexus threshold and every country where you owe VAT. Register and file the gaps, or disclose them fully. This is the fastest-growing claim category.
• Material contracts. Confirm your platform agreements, 3PL contract, key supplier terms, and wholesale relationships are actually in writing and actually assignable. One brand we saw had two key wholesale reps generating real revenue with no signed contract at all. If you represent that all material contracts are in writing and they are not, that is a breach on its face.
• IP chain of title. Covered above, and worth repeating: it is the only item here that can kill the deal rather than reprice it.

The founders who exit cleanest are the ones who ran their own diligence a year before the buyer did. Every number a QoE team restates is a number you could have restated yourself, on your own timeline, without a claim attached. The reps section is not where you get caught. It is where you get rewarded for having already cleaned up.

Sources and methodology

R&W claim frequency and category data is compiled from insurer and law-firm market studies. Claim-frequency ranges (15-20%), the ~71% payment concentration in financial statements plus material contracts, and severity patterns are drawn from Hunton Andrews Kurth's R&W insurance fundamentals guide, which synthesizes Aon M&A & Transaction Solutions underwriting data, and Cooley LLP's June 2024 market update.

Deal-structure terms come from the two standard private-target studies. No-survival prevalence, rep prevalence (the 97% "fair presentation of financials" figure), and survival-period distributions are from the ABA 2025 Private Target M&A Deal Points Study. Escrow percentages and RWI-versus-non-RWI structure data are from the SRS Acquiom 2025 Deal Terms Study public summary.

Undisclosed-liability and breach-claim category trends are from SRS Acquiom's claims dataset. The finding that tax and capitalization reps drive over half of breach claims, and that undisclosed-liability claims have more than doubled since 2022 to 24% of R&W indemnification claims, is from the SRS Acquiom 2025 M&A Claims Insights Report summary.

IP as a deal-killer is drawn from transactional-counsel guidance and academic analysis. The treatment of anti-assignment clauses as termination-level deal-breakers is from Mayer Brown's 2025 tech M&A reps guidance. The 46-60% transaction-failure rate linked in part to IP due diligence gaps is from an SSRN analysis of IP due diligence in M&A.

What we did not fabricate. Per-category payment shares outside financial statements and material contracts are not publicly broken out, so those cells are shown as directional rather than precise. No DTC-specific claim-frequency rate exists in the public insurer data; the 15-20% market rate is applied across sectors. Operator situations are anonymized and figures are used without identifying any business.

Frequently asked questions